1887

Abstract

Although the current Zika virus (ZIKV) epidemic is a major public health concern, most reports have focused on congenital ZIKV syndrome, its most devastating manifestation. Severe ocular complications associated with ZIKV infections and possible pathogenetic factors are rarely described. Here, we describe three Venezuelan patients who developed severe ocular manifestations following ZIKV infections. We also analyse their serological response to ZIKV and dengue virus (DENV).

One adult with bilateral optic neuritis, a child of 4 years of age with retrobulbar uveitis and a newborn with bilateral congenital glaucoma had a recent history of an acute exanthematous infection consistent with ZIKV infection. The results of ELISA tests indicated that all patients were seropositive for ZIKV and four DENV serotypes.

Patients with ZIKV infection can develop severe ocular complications. Anti-DENV antibodies from previous infections could play a role in the pathogenesis of these complications. Well-designed epidemiological studies are urgently needed to measure the risk of ZIKV ocular complications and confirm whether they are associated with the presence of anti-flaviviral antibodies.

Loading

Article metrics loading...

/content/journal/jmmcr/10.1099/jmmcr.0.005145
2018-05-01
2019-12-06
Loading full text...

Full text loading...

/deliver/fulltext/jmmcr/5/5/jmmcr005145.html?itemId=/content/journal/jmmcr/10.1099/jmmcr.0.005145&mimeType=html&fmt=ahah

References

  1. Dick GW, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg 1952;46:509–520 [CrossRef][PubMed]
    [Google Scholar]
  2. Dick GW. Zika virus. II. Pathogenicity and physical properties. Trans R Soc Trop Med Hyg 1952;46:521–534 [CrossRef][PubMed]
    [Google Scholar]
  3. Duffy MR, Chen TH, Hancock WT, Powers AM, Kool JL et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 2009;360:2536–2543 [CrossRef][PubMed]
    [Google Scholar]
  4. CDC 2016; Zika Virus [online]. Available fromwww.cdc.gov/zika/ [updated February 12, 2016]
  5. CDC 2016; ZIka virus: symptoms, diagnosis & treatment: centers for disease control and prevention. Available fromwww.cdc.gov/zika/symptoms/index.html
  6. Bethesda 2015; Guillain-Barré syndrome fact sheet: NIH. Available fromwww.ninds.nih.gov/disorders/gbs/detail_gbs.htm
  7. Mlakar J, Korva M, Tul N, Popović M, Poljšak-Prijatelj M et al. Zika virus associated with microcephaly. N Engl J Med 2016;374:951–958 [CrossRef][PubMed]
    [Google Scholar]
  8. WHO Zika virus, microcephaly and Guillain–Barré syndrome situation report.: World Health Organization. 2016
  9. Ventura CV, Ventura LO, Bravo-Filho V, Martins TT, Berrocal AM et al. Optical coherence tomography of retinal lesions in infants with congenital Zika syndrome. JAMA Ophthalmol 2016;134:1420–1427 [CrossRef][PubMed]
    [Google Scholar]
  10. Ventura CV, Maia M, Dias N, Ventura LO, Belfort R. Zika: neurological and ocular findings in infant without microcephaly. Lancet 2016;387:2502 [CrossRef][PubMed]
    [Google Scholar]
  11. de Andrade GC, Ventura CV, Mello Filho PA, Maia M, Vianello S et al. Arboviruses and the eye. Int J Retina Vitreous 2017;3:1 [CrossRef][PubMed]
    [Google Scholar]
  12. Yepez JB, Murati FA, Pettito M, Peñaranda CF, de Yepez J et al. Ophthalmic manifestations of congenital Zika syndrome in Colombia and Venezuela. JAMA Ophthalmol 2017;135:440–445 [CrossRef][PubMed]
    [Google Scholar]
  13. Parke DW, Almeida DR, Albini TA, Ventura CV, Berrocal AM et al. Serologically confirmed Zika-related unilateral acute maculopathy in an adult. Ophthalmology 2016;123:2432–2433 [CrossRef][PubMed]
    [Google Scholar]
  14. Wong CW, Ng SR, Cheung CM, Wong TY, Mathur R. Zika-related maculopathy. Retin Cases Brief Rep 2017; [CrossRef][PubMed]
    [Google Scholar]
  15. Furtado JM, Espósito DL, Klein TM, Teixeira-Pinto T, da Fonseca BA. Uveitis associated with Zika virus infection. N Engl J Med 2016;375:394–396 [CrossRef][PubMed]
    [Google Scholar]
  16. Kodati S, Palmore TN, Spellman FA, Cunningham D, Weistrop B et al. Bilateral posterior uveitis associated with Zika virus infection. Lancet 2017;389:125–126 [CrossRef][PubMed]
    [Google Scholar]
  17. Lalitha P, Rathinam S, Banushree K, Maheshkumar S, Vijayakumar R et al. Ocular involvement associated with an epidemic outbreak of chikungunya virus infection. Am J Ophthalmol 2007;144:552–556 [CrossRef][PubMed]
    [Google Scholar]
  18. Khairallah M, Kahloun R. Ocular manifestations of emerging infectious diseases. Curr Opin Ophthalmol 2013;24:574–580 [CrossRef][PubMed]
    [Google Scholar]
  19. Ventura CV, Maia M, Travassos SB, Martins TT, Patriota F et al. Risk factors associated with the ophthalmoscopic findings identified in infants with presumed Zika virus congenital infection. JAMA Ophthalmol 2016;134:912–918 [CrossRef][PubMed]
    [Google Scholar]
  20. Coyne CB, Lazear HM. Zika virus - reigniting the TORCH. Nat Rev Microbiol 2016;14:707–715 [CrossRef][PubMed]
    [Google Scholar]
  21. Schwartz DA. The origins and emergence of Zika virus, the newest TORCH infection: what's old is new again. Arch Pathol Lab Med 2017;141:18–25 [CrossRef][PubMed]
    [Google Scholar]
  22. de Paula Freitas B, Ko AI, Khouri R, Mayoral M, Henriques DF et al. Glaucoma and congenital Zika syndrome. Ophthalmology 2017;124:407–408 [CrossRef][PubMed]
    [Google Scholar]
  23. Zimmerman LE. Histopathologic basis for ocular manifestations of congenital rubella syndrome. Am J Ophthalmol 1968;65:837–862 [CrossRef][PubMed]
    [Google Scholar]
  24. O'Neill JF. The ocular manifestations of congenital infection: a study of the early effect and long-term outcome of maternally transmitted rubella and toxoplasmosis. Trans Am Ophthalmol Soc 1998;96:813–879[PubMed]
    [Google Scholar]
  25. Bardina SV, Bunduc P, Tripathi S, Duehr J, Frere JJ et al. Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science 2017;356:175–180 [CrossRef][PubMed]
    [Google Scholar]
  26. Halstead SB. Critique of World Health Organization recommendation of a dengue vaccine. J Infect Dis 2016;214:1793–1795 [CrossRef][PubMed]
    [Google Scholar]
  27. Dejnirattisai W, Supasa P, Wongwiwat W, Rouvinski A, Barba-Spaeth G et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol 2016;17:1102–1108 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmmcr/10.1099/jmmcr.0.005145
Loading
/content/journal/jmmcr/10.1099/jmmcr.0.005145
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error